Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Alasdair Geddes"'
Publikováno v:
Journal of Antimicrobial Chemotherapy. 75:2375-2375
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c2ce22e482d532efed87299be7d7336
https://doi.org/10.1093/jac/dkaa225
https://doi.org/10.1093/jac/dkaa225
Autor:
G.N. Rolinson, Alasdair Geddes
Publikováno v:
International Journal of Antimicrobial Agents. 29:3-8
This year (2007) marks the 50th anniversary of [corrected] discovery of 6-aminopenicillanic acid (6-APA), the precursor of all semi-synthetic penicillins [corrected] This review, by a scientist who played a major part in the discovery and a physician
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c8c0de6fc45e6be7a33df402deaec1d
https://doi.org/10.1016/j.ijantimicag.2006.09.003
https://doi.org/10.1016/j.ijantimicag.2006.09.003
Autor:
Alasdair Geddes, Kurt G. Naber
Publikováno v:
International journal of antimicrobial agents. 45(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1f2a1f6926fbd0271f78b32b033d9d1
https://pubmed.ncbi.nlm.nih.gov/26185814
https://pubmed.ncbi.nlm.nih.gov/26185814
Autor:
Alasdair Geddes
Publikováno v:
Journal of Antimicrobial Chemotherapy. 71:283-284
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ede291e019d638835b5df4a520f881e
https://doi.org/10.1093/jac/dkv401
https://doi.org/10.1093/jac/dkv401
Autor:
Alasdair Geddes
Publikováno v:
Journal of Antimicrobial Chemotherapy. 72:1847-1847
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4d0f97e6c4c3a2218df2ba0e3d1be95
https://doi.org/10.1093/jac/dkx075
https://doi.org/10.1093/jac/dkx075
Autor:
Alasdair Geddes
Publikováno v:
Journal of Antimicrobial Chemotherapy. 46:873-877
The late Paul Garrod, in whose honour this lecture is named, was 'the right man at the right time'. He seized the opportunities offered by the dawning of the chemotherapeutic era with vigour and enthusiasm and was a formidable link between the tradit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::952b9b47c9abf8abb33eb8aa4817982f
https://doi.org/10.1093/jac/46.6.873
https://doi.org/10.1093/jac/46.6.873
Grepafloxacin: an overview of antibacterial activity, pharmacokinetics, clinical efficacy and safety
Autor:
Alasdair Geddes
Publikováno v:
Expert Opinion on Investigational Drugs. 8:487-505
The treatment of respiratory tract infection is the most common reason for antibiotic prescribing. However, therapeutic options are diminishing as antibiotic resistance to penicillins and macrolides in key respiratory pathogens is increasing. As resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6288ae72d9cb81c3b33580e439032217
https://doi.org/10.1517/13543784.8.4.487
https://doi.org/10.1517/13543784.8.4.487
Publikováno v:
Journal of Antimicrobial Chemotherapy. 37:135-144
A total of 686 adult patients with complicated urinary tract infections were enrolled in a double-blind, randomised, multicentre study to compare sparfloxacin (200 mg loading dose on day 1 followed by 100 mg daily) with ciprofloxacin (500 mg orally t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14e131a81f916ff24ec5b848ea030e7e
https://doi.org/10.1093/jac/37.suppl_a.135
https://doi.org/10.1093/jac/37.suppl_a.135
Publikováno v:
International Journal of Antimicrobial Agents. 2:203-230
Within the past decade several new fluoroquinolones (norfloxacin, enoxacin, ofloxacin, ciprofloxacin, pefloxacin, temafloxacin and lomefloxacin) have been introduced into therapy. All these agents share a broad spectrum of activity against a variety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cefb9c68792be6f1e80e8ebe00cdc90
https://doi.org/10.1016/0924-8579(93)90055-a
https://doi.org/10.1016/0924-8579(93)90055-a
